J. N. Sarkaria
All authors
About
Publications While At HealthPartners
selected publications
Journal Article
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)
.
Journal of Neuro-Oncology.
2019
Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572
.
Cancer.
2018
Contact
full name
J. N.
Sarkaria
Quick Info
Collaboration
Co-author network
Map of science